The global medical plastics market size is expected to reach USD 87.58 billion by 2030, registering a CAGR of 7.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The demand for medical device packaging is likely due to the increased need for in-house and advanced medical devices. Plastics including polyethylene, polypropylene, and polycarbonate are increasingly being utilized in the medical device manufacturing The growth of the home healthcare sector on account of the low costs involved as compared to hospital care and intensive care contributes to a rise in the demand for medical devices and multiple hospital associated tests as well.
The growth of the home healthcare sector on account of the low costs involved as compared to hospital care and intensive care has resulted in a rise in the demand for medical devices. The increasing demand for medical devices can also be attributed to the various types of medical tests conducted by hospitals for diagnostic purposes.
Healthcare spending in the country is likely to accelerate in the near future owing to the growing awareness about healthcare. The rise in demand is driven by the aging population (65 years of age or above), growing prevalence of chronic diseases, infrastructure enhancements and technological advancements in medical plastics market.
The strengthening of the Western European economies is expected to result in an increased provision of healthcare expenditure in the annual budgetary proposals. Moreover, Northern European economies such as Germany, the UK, and Sweden are projected to exhibit an increase in healthcare expenditure, thereby leading to a growth in the production of medical devices. However, the growth is expected to be supported by political unrest in Europe’s transition economies such as Russia and Ukraine.
Request a free sample copy or view report summary: Medical Plastic Market Report
Based on product, the Polyphenylsulfone (PPSU) resin dominated product segmentation for 2023 in terms of revenue share above 51.0%, due to the heat and chemical resistance of PPSU. These plastics possess high strength and durability, making essential surgical tools.
Asia Pacific possessed a high market share in 2023, due to increasing healthcare expenditure. However, Governments in China, India and Japan are investing heavily, to prevent rising chronic diseases and upgrading healthcare infrastructures. Per capita healthcare spending is elevating, setting the stage for healthcare revolution in the region.
Regulations are the key factor influencing the medical device industry, thereby influencing the medical plastics market in Europe and North America. Rising government concerns regarding the offering of high-quality, safe, and effective medical devices are expected to have a negative impact on the market growth over the forecast period.
Grand View Research has segmented the global medical plastic market based on product, application, and region:
Medical Plastics Product Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)
Polyethylene (PE)
Polypropylene (PP)
Polycarbonate (PC)
Liquid Crystal Polymer (LCP)
Polyphenylsulfone (PPSU)
Polyethersulfone (PES)
Polyethylenimine (PEI)
Polymethyl Methacrylate (PMMA)
Others
Medical Plastics Process Technology Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
Extrusion
Injection Molding
Blow Molding
Other
Medical Plastics Application Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)
Medical Device Packaging
Medical Components
Orthopedic Implant Packaging
Orthopedic Soft Goods
Wound Care
Cleanroom Supplies
BioPharm Devices
Mobility Aids
Sterilization and Infection Prevention
Tooth Implants
Denture Base Material
Other Implants
Others
Medical Plastics Region Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Netherland
Asia Pacific
China
India
Japan
Central & South America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
UAE
List of Key Players in the Medical Plastics Market
Röchling SE & Co. KG
Nolato AB
Saint-Gobain S.A.
SABIC
Orthoplastics Ltd
Eastman Chemical Company
Celanese Corporation
Dow, Inc.
Tekni-Plex, Inc.
Solvay S.A.
HMC Polymers Company Limited
ARAN BIOMEDICAL TEORANTA
Trelleborg Group
Avantor, Inc.
Trinseo
Evonik Industries AG
"The quality of research they have done for us has been excellent..."